
CapMan Life Science invests in Swereco
CapMan has invested in Swereco AB through its CapMan Life Science IV fund.
The company produces ergonomic products primarily designed for the physically challenged. CapMan's investment will support an acceleration of the company's expansion and a strengthening of the existing business model.
Swereco was founded in 1973 and recorded net sales of approximately €5.5m in 2009. CapMan will together with Svenskt Företagskapital be the main owners of the company.
The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.
If you have any information regarding this transaction, please contact Viktor Lundvall on +44 20 7004 7476 or viktor.lundvall@incisivemedia.com
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater